ChemSpider 2D Image | Atracurium | C65H82N2O18S2

Atracurium

  • Molecular FormulaC65H82N2O18S2
  • Average mass1243.479 Da
  • Monoisotopic mass1242.500366 Da
  • ChemSpider ID56614
  • Charge - Charge

    defined stereocentres - 4 of 4 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(1R,2R,1'R,2'R)-2,2'-{1,5-Pentandiylbis[oxy(3-oxo-3,1-propandiyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisochinolinium]dibenzolsulfonat [German] [ACD/IUPAC Name]
(1R,2R,1'R,2'R)-2,2'-{1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate [ACD/IUPAC Name]
(1R,2R,1'R,2'R)-2,2'-{Pentan-1,5-diylbis[oxy(3-oxopropan-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisochinolinium]bisbenzolsulfonat
(1R,2R,1'R,2'R)-2,2'-{Pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
(1R-cis,1'R-cis)-Atracurium besylate
[1R-[1a,2a(1'R*,2'R*)]]-2,2'[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolinium] Dibenzenesulfonate
7389
80YS8O1MBS
96946-42-8 [RN]
Atracurium [Wiki]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

D00759 [DBID]
NCGC00017127-01 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Target Organs:

      AChR antagonist;Adrenergic Receptor antagonist TargetMol T1459
    • Chemical Class:

      The (1<stereo>R</stereo>,1'<stereo>R</stereo>,2<stereo>R</stereo>,2'<stereo>R</stereo>)-diastereoisomer of atracurium besylate. Commercial preparations of atracurium are mixtures of 10 stereoisomers, of which cisatracurium generally constitutes about 15%. Cisatracurium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a m uscle relaxant for endotracheal intubation, to aid controlled ventilation, and in general anaesthesia. ChEBI CHEBI:3721
      The (1R,1'R,2R,2'R)-diastereoisomer of atracurium besylate. Commercial preparations of atracurium are mixtures of 10 stereoisomers, ; of which cisatracurium generally constitutes about 15%. Cisatracur ium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a muscle relaxant for endotracheal intubation, to aid controlled vent ilation, and in general anaesthesia. ChEBI https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3721
    • Bio Activity:

      AChR;Adrenergic receptor TargetMol T1459
      Cisatracurium Besylate is a nondepolarizing neuromuscular blocking agent, antagonizing the action of acetylcholine by inhibiting neuromuscular transmission. MedChem Express
      Cisatracurium Besylate is a nondepolarizing neuromuscular blocking agent, antagonizing the action of acetylcholine by inhibiting neuromuscular transmission.; Target: AChR alpha-2; Cisatracurium is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. MedChem Express HY-13596
      Cisatracurium Besylate is a nondepolarizing neuromuscular blocking agent, antagonizing the action of acetylcholine by inhibiting neuromuscular transmission.;Target: AChR alpha-2Cisatracurium is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is a bisbenzyltetrahydroisoquinolinium agent with an intermediate duration of action. Cisatracurium is one of the ten isomers of the parent molecule, atracurium. Moreover, cisatracurium represents approximately 15% of the atracurium mixture [1, 2]. MedChem Express HY-13596
      Membrane Tranporter/Ion Channel MedChem Express HY-13596
      Membrane Tranporter/Ion Channel; Neuronal Signaling; MedChem Express HY-13596
      nAChR MedChem Express HY-13596
      Neuroscience;GPCR/G protein TargetMol T1459

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site






Advertisement